Showing results (671-680 of 718) with videos related to
Sort By:
Pageof 72
The Oncologist|July 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumorsDan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2023
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung CancerCharles M Rudin, Stephen V Liu, Ross A Soo, et al.The Oncologist|April 12, 2026
Phase 2 Study of Cabozantinib (XL184) with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas (ETCTN10315)Adel Mandl, Ruizhe Chen, Satya Das, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2021
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung CancerRafal Dziadziuszko, Matthew G Krebs, Filippo De Braud, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancerJ J Lin, S V Liu, C E McCoach, et al.Cancer Research|October 1, 2021
Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential TherapyJunyu Yang, Chong Gao, Miao Liu, et al.Lung Cancer (Amsterdam, Netherlands)|September 22, 2024
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension studyMartin Reck, Rafal Dziadziuszko, Shunichi Sugawara, et al.Cancer Medicine|December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancerDavid G Pfister, Robert I Haddad, Francis P Worden, et al.Nature Reviews. Clinical Oncology|March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.Lung Cancer (Amsterdam, Netherlands)|November 6, 2023
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposideStephen V Liu, Tony S K Mok, Barzin Y Nabet, et al.Pageof 72